Po Yu Chen's most recent trade in Alto Neuroscience Inc. was a trade of 83,333 Series B Preferred Stock done . Disclosure was reported to the exchange on Feb. 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alto Neuroscience Inc. | Po Yu Chen | Director | 06 Feb 2024 | 83,333 | 0 | - | - | Series B Preferred Stock | ||
Alto Neuroscience Inc. | Po Yu Chen | Director | 06 Feb 2024 | 39,259 | 39,259 | - | - | Common Stock | ||
Alto Neuroscience Inc. | Po Yu Chen | Director | 06 Feb 2024 | 18,794 | 0 | - | - | Series C Preferred Stock | ||
Alto Neuroscience Inc. | Po Yu Chen | Director | 06 Feb 2024 | 8,450 | 47,709 | - | - | Common Stock | ||
Alto Neuroscience Inc. | Po Yu Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
Alto Neuroscience Inc. | Po Yu Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,540 | 1,540 | - | - | Stock Option (right to buy) |